Company intelligence / Profile preview

Arctoris

Abingdon, England, United Kingdomarctoris.com ↗
Ownership
Private
Employees
~35
Development stage
Other
01

Overview

Arctoris has demonstrated the ability to accelerate early-stage drug discovery using its Ulysses automation/data science platform. The company has active programs in oncology and neurodegeneration at the preclinical/discovery stage, with additional partnered projects spanning multiple therapeutic areas. No clinical results have been published as of June 2025.

Therapeutic areas
OtherOncologyNeurologyInfectious Diseases
Modalities
Small moleculeRNA therapy (inferred from microRNA research focus)Biologic (inferred from protein science and structural biology capabilities)Antibody (inferred from broad drug discovery platform and typical biotech focus)
Industry
Biotech
02

Partnerships

SpiroChem AG – strategic partnership for integrated biology/chemistry drug discovery solutions combining automated biology with advanced chemistry platforms.Cyclica – collaboration on neurodegenerative disease program.InSilico Medicine – collaboration on COVID‑19/JAK inhibitor program.Multiple undisclosed biotech/pharma partners globally across North America, Europe, Asia-Pacific.

Beyond the preview

Go deeper on Arctoris.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arctoris.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call